A Study of LY2157299 in Healthy Participants
| Status: | Completed |
|---|---|
| Conditions: | Healthy Studies |
| Therapuetic Areas: | Other |
| Healthy: | No |
| Age Range: | 21 - 65 |
| Updated: | 11/30/2013 |
| Start Date: | October 2013 |
| End Date: | November 2013 |
| Contact: | There may be multiple sites in this clinical trial. 1-877-CTLILLY (1-877-285-4559) or |
| Phone: | 1-317-615-4559 |
Effect of Food on the Pharmacokinetics of LY2157299 Monohydrate in Healthy Subjects
Participants in this study will receive two oral doses of 150 milligram (mg) LY2157299 taken
at least 4 days apart. One dose will be given without food. One dose will be given with a
high fat meal. The study will evaluate the effect of a high fat meal on how much of the
drug gets into the blood stream. Side effects will be documented. This study will last
approximately 15 days not including screening. Screening is required within 30 days prior to
the start of the study.
Inclusion Criteria:
- Healthy sterile males or females
- Are able to eat a high fat meal
- No abnormal heart function or high blood pressure
- No participation in a clinical trial within 30 days
- No evidence of human deficiency virus (HIV), hepatitis C or hepatitis B
Exclusion Criteria:
- Have a clinically significant abnormality in the 12-lead electrocardiogram (ECG)
that, in the opinion of the investigator, increases the risks associated with
participating in the study
We found this trial at
1
site
Click here to add this to my saved trials
